


Frontier Biotechnologies Inc Revenue
Pharmaceutical Manufacturing • Jianye District, Jiangsu, China • 11-20 Employees
Frontier Biotechnologies Inc revenue & valuation
| Annual revenue | $4,300,000 |
| Revenue per employee | $239,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Pharmaceutical Manufacturing industry and current estimated revenues | $13,800,000 |
| Total funding | No funding |
Key Contacts at Frontier Biotechnologies Inc
Zhina Hu
Associate Director Of International Division
Changjin Wang
Chief Executive Officer
Company overview
| Headquarters | Jianye District, Jiangsu, China |
| Phone number | +862569760330 |
| Website | |
| NAICS | 3254 |
| Keywords | Pharmaceutical, HIV, Aids, Albuvirtide, Fusion Inhibitor, Medicine Production, Long Acting |
| Founded | 2002 |
| Employees | 11-20 |
| Socials |
Frontier Biotechnologies Inc Email Formats
Frontier Biotechnologies Inc uses 1 email format. The most common is {first initial}{last name} (e.g., jdoe@frontierbiotech.com), used 100% of the time.
| Format | Example | Percentage |
|---|---|---|
{first initial}{last name} | jdoe@frontierbiotech.com | 100% |
About Frontier Biotechnologies Inc
Frontier Biotech is a research-based, clinical stage pharmaceutical company utilizing cross-Pacific drug discovery and development business model. The management team have extensive business and development experiences in the US and China pharma/biotech industry. Frontier Biotech leverages China's large patient population, and rapid growing economy and pharmaceutical market, develops innovative pharmaceutical products with worldwide IP protection and to be marketed in the near future. We are dedicated in the discovery, development and commercialization of innovative therapeutic products for unmet medical needs and under-served patients. Our lead product candidate, Albuvirtide, is a treatment-paradigm shifting long-acting HIV fusion inhibitor for the treatment of HIV infection and AIDS. An NDA was accepted by Chinese FDA in July 2016. Albuvirtide could become the first long-acting anti-HIV new drug worldwide.
Employees by Management Level
Total employees: 11-20
Seniority
Employees
Employees by Department
Frontier Biotechnologies Inc has 3 employees across 3 departments.
Departments
Number of employees
Frequently asked questions
4.8
40,000 users



